Correlates of left ventricular mass in hypertensive Nigerians: An echocardiographic study

Cardiovascular Journal of Africa

Volumn 21, Issue 2, 2010, Pages 79-85

  Ogah, Okechukwu S ^a   Bamgboye, Afolabi E ^b  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Correlates; Determinants; Hypertension; Left ventricular mass; Nigeria

Indexed keywords

NEUROHORMONE;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTERY DIAMETER; ARTICLE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE;

BLOOD PRESSURE MONITORING, AMBULATORY; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 77951610148     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med 1990; 322: 1561.
2. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 1998; 31(2): 383-390.
3. Levy D. Clinical significance of left ventricular hypertrophy: insights from the Framingham study. J Cardiovasc Pharmacol 1991; 17(Suppl 2): S1-6.
4. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90(4): 1786-1793.
5. Galderisi M, Lauer MS, Levy D. Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). Am J Cardiol 1992; 70(11): 971-976.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart study. Ann Intern Med 1989; 110(2): 101-107.
7. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 60(7): 560-565. (Pubitemid 17138871)
8. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study. N Engl J Med 1990; 322(22): 1561-1566.
9. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1996; 78(2): 197-202.
10. Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359(9311): 995-1003. (Pubitemid 34286536)
11. Kjeldsen SE, Dahlof B, Devereux RB, et al. Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens 2000; 13(8): 899-906.
12. Wachtell K, Olsen MH, Dahlof B, et al. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002; 20(3): 405-412. (Pubitemid 34913739)
13. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (The JNC 7 Report). J Am Med Assoc 2003; 289(19): 2560-2572.
14. Adebiyi AA, Ogah OS, Aje A, et al. Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians. BMC Med Imaging 2006; 6: 10.
15. Du Bois D, Du Bois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17: 863-867.
16. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
17. Adebiyi AA, AJE A, Ogah OS, et al. Correlates of left atrial size in Nigerian hypertensives. Cardiovasc J South Afr 2005; 16(3): 201-204.
18. Devereux RB, E.M L, Casale PN, et al. Standardization of M-Mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222.
19. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 1995; 25(1): 83-90.
20. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determination: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol 1976; 37: 7-11.
21. Devereux RB, Roman MJ, Paranicas M, et al. Relation of Doppler stroke distance and aortic annular diameter to left ventricular stroke volume in normotensive and hypertensive American Indians: the strong Heart study. Am J Hypertens 1997; 10: 619-628.
22. Ferguson JJ, Julius S, Randall OS. Stroke volume:pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens 1984; 2(Suppl 3): 397-399.
23. Randall OS, Westerhof N, VanDen Bos GC, Alexander B. Reliability of stroke volume to pulse pressure ratio for estimating and detecting changes in arterial compliance. J Hypertens 1986; 4(Suppl 5): S293-S296.
24. Liebson PR, Granditis G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment Of Mild Hypertension Study (TOHMS). Circulation 1993; 87: 476.
25. Tingleff J, Munch M, Jakobsen TJ, et al. Prevalence of left ventricular hypertrophy in a hypertensive population. Eur Heart J 1996; 17(1): 143-149.
26. Tingleff J, Munch M, Jakobsen TJ, et al. [Prevalence of left ventricular hypertrophy in Danish patients with hypertension]. Ugeskr Laeger 1997; 159(37): 5529-5533.
27. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19(7): 1550-1558.
28. Ganau A, Saba PS, Roman MJ, de Simone G, Realdi G, Devereux RB. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995; 13(12 Pt 2): 1818-1822.
29. Jones EC, Devereaux RB, O'Grady MJ, et al. Relation of haemodynamic load to arterial and cardiac size. J Am Coll Cardiol 1997; 29:1303-1310.
30. Dahan M, Siohan P, Viron B, et al. Relationship between Left ventricular hypertrophy, myocardial contractility, and load conditions in haemodialysis patients: an echocardiographic study. Am J Kidney Dis 1997; 30: 780-785.
31. Chen C, Ting C, Lin S, et al. Which arterial and cardiac parameters best predict left ventricular mass? Circulation 1998; 98: 422-428.
32. Lakatta EG. Similar myocardial effects of aging and hypertension. Eur Heart J 1990; 11(Suppl G): 29-38.
33. Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol 1991; 17(3): 717-721.
34. Sax FL, Brush JE, Cannon RO, et al. Impaired left ventricular filling in symptomatic compared to asymptomatic hypertensive patients (abstract). J Am Coll Cardiol 1988; 11: 81A.
35. Schunkert H. Obesity and target organ damage: the heart. Int J Obes Relat Metab Disord 2002; 26(Suppl 4): S15-20.
36. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass:The Framingham Heart study. Hypertension 1997; 30: 1025-1028.
37. Messerli FH. Clinical Determinants and Manifestations of Left Ventricular Hypertrophy. New York: Yorke Medical Books, 1987.
38. Rasooly Y, Sasson Z, Gupta R. Relation between body fat distribution and left ventricular mass in men without structural heart disease or systemic hypertension. Am J Cardiol 1993; 71: 1477.
39. Dannenberg AL, Levy D, Garrison RJ. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham study). Am J Cardiol 1989; 64: 1066.
40. Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90(2): 928-936.
41. Koenig H, Goldstone A, Lu CY. Testosterone-medicated sexual dimorphism in the rodent heart: Ventricular lysosomes, mitochondria, and cell growth are modulated by androgens. Circ Res 1982; 50: 782.
42. Devereaux RB. Towards a more understanding of left ventricular after-load. J Am Coll Cardiol 1991; 17: 122-124.